🔎 Trials Near Me

Home › Small Cell Lung Cancer › Nebraska › Omaha

Small Cell Lung Cancer clinical trials in Omaha, NE

8 studies for Small Cell Lung Cancer are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

RecruitingPhase 1
  • Oncology Hematology West, PC dba Nebraska Cancer Specialists, Omaha
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT03460977

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

RecruitingPhase 1/2
  • Nebraska Cancer Specialists, Omaha
  • XCancer, Omaha
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07189871

DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy

RecruitingPhase 3
  • University of Nebraska Medical Center, Omaha
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07472517

Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

RecruitingPhase 1/2
  • Nebraska Cancer Specialists, Omaha
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07278479

Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)

RecruitingPhase 3
  • Oncology Hematology West PC, Omaha
Ages 18 to 99 · All sexes · Updated Sep 17, 2026 · NCT07778316

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

RecruitingPhase 3
  • University of Nebraska Medical Center, Omaha
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT06203210

Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

RecruitingPhase 1/2
  • Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
Ages 18 and older · All sexes · Updated Mar 11, 2026 · NCT06681220

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

RecruitingPhase 1/2
  • Nebraska Cancer Specialists, Omaha
Ages 18 and older · All sexes · Updated Feb 18, 2026 · NCT07030257

Small Cell Lung Cancer trials in other cities

Other studies in Omaha

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.